Welcome to our dedicated page for Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on Cigna Group stock.
The Cigna Group (NYSE: CI) news hub provides investors and healthcare professionals with timely updates on this global health services leader. Track official announcements, earnings reports, and strategic developments from Cigna's Evernorth Health Services pharmacy platform and Cigna Healthcare insurance division.
This page aggregates essential updates including regulatory filings, partnership announcements, and innovations in pharmacy benefit management. Stay informed about CI's initiatives in biosimilars adoption, digital health expansion, and value-based care models shaping the healthcare landscape.
Key coverage areas include quarterly financial results, Medicare Advantage updates, international market entries, and leadership changes. All content is sourced from verified corporate communications and reputable financial analysis to ensure reliability.
Bookmark this page for streamlined access to CI's latest developments affecting healthcare markets and investor decisions. Combine our news feed with SEC filings and earnings call transcripts for comprehensive research.
Express Scripts, part of Evernorth under The Cigna Group (NYSE: CI), reported that members with employer-sponsored insurance saw a 1% decrease in out-of-pocket prescription costs in 2023, averaging $15.10 for a 30-day supply, despite a price increase for 60% of branded drugs. Their negotiations and innovative solutions contributed to these savings, even with rising consumer prices.
Four in five members spent less than $250 annually on medications. The Patient Assurance Program capped diabetes medication costs at $25 for a 34-day supply, leading to $92 million in savings. This highlights Express Scripts' efforts to manage drug prices and ensure affordability for patients.
Express Scripts, part of The Cigna Group's Evernorth, announced a collaboration with CPESN USA to improve healthcare access at independent pharmacies. Guided by its Independent Pharmacy Advisory Committee, Express Scripts aims to enhance care services, initially focusing on Medicare beneficiaries with hypertension and diabetes. The collaboration will involve over 3,500 CPESN pharmacies in 44 states, providing services such as care coordination, identifying at-risk patients, and optimizing medication management. This initiative supports Express Scripts' broader goal of strengthening the role of independent pharmacists in community health and reducing healthcare costs.
The Cigna Group (NYSE:CI) has announced that Brian Evanko, EVP and CFO of The Cigna Group, and President and CEO of Cigna Healthcare, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL.
The presentation is scheduled for 10:00 a.m. ET and will be available via a live webcast on The Cigna Group's Investor Relations website. Investors interested in listening live should visit the site 15 minutes prior to the start time to download and install necessary audio software.
Global health company The Cigna Group (NYSE: CI) has climbed to No. 7 on Fair360's 2024 Top 50 Companies list, improving by seven spots from 2023. The ranking highlights The Cigna Group's commitment to workplace fairness, diversity, and community support. Key accomplishments include surpassing their $1 billion annual spending goal with small and diverse businesses by $400 million ahead of schedule, and pledging $1.6 billion annually by 2025. The company also announced a new philanthropic initiative, committing $27 million in grants over three years to support youth mental health, veterans' housing stability, and health equity in high-risk communities.
The Cigna Group reported strong first quarter 2024 results with $57.3 billion in total revenues, a net loss of $0.3 billion, adjusted income from operations of $1.9 billion, and raised their 2024 outlook to at least $28.40 per share. Shareholders experienced a net loss due to an investment loss related to VillageMD equity securities. Despite this, the company remains optimistic about its strong performance and growth trajectory.
FAQ
What is the current stock price of Cigna Group (CI)?
What is the market cap of Cigna Group (CI)?
